This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Nov-Dec;6(6):393-401.

doi: 10.2165/00002018-199106060-00001.

Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks

U Ravens¹, M Wehr

Affiliations

PMID: 1793520
DOI: 10.2165/00002018-199106060-00001

Review

Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks

U Ravens et al. Drug Saf. 1991 Nov-Dec.

. 1991 Nov-Dec;6(6):393-401.

doi: 10.2165/00002018-199106060-00001.

Authors

U Ravens¹, M Wehr

Affiliation

¹ Institut für Pharmaokologie, Universität-GHS-Essen, Germany.

PMID: 1793520
DOI: 10.2165/00002018-199106060-00001

No abstract available

PubMed Disclaimer

Similar articles

Current status of phosphodiesterase inhibitors in the treatment of congestive heart failure.
Fischer TA, Erbel R, Treese N. Fischer TA, et al. Drugs. 1992 Dec;44(6):928-45. doi: 10.2165/00003495-199244060-00003. Drugs. 1992. PMID: 1282864 Review.
Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.
Todd PA, Goa KL. Todd PA, et al. Drugs. 1989 Feb;37(2):141-61. doi: 10.2165/00003495-198937020-00004. Drugs. 1989. PMID: 2539290 Review.
[Present day opinion about beta block treatment of congestive heart failure].
Nessler J. Nessler J. Przegl Lek. 1998;55(12):669-72. Przegl Lek. 1998. PMID: 10354719 Review. Polish.
An overview of integration of therapy for congestive heart failure.
Parmley WW. Parmley WW. J Cardiovasc Pharmacol. 1989;14 Suppl 5:S73-7. J Cardiovasc Pharmacol. 1989. PMID: 2478815 Review.
Heart failure treatments: issues of safety versus issues of quality of life.
Feenstra J, Lubsen J, Grobbee DE, Stricker BH. Feenstra J, et al. Drug Saf. 1999 Jan;20(1):1-7. doi: 10.2165/00002018-199920010-00001. Drug Saf. 1999. PMID: 9935272 Review.

See all similar articles

References

1. Ann Intern Med. 1988 Jul 1;109(1):55-61 - PubMed
1. Lancet. 1979 Jun 30;1(8131):1374-6 - PubMed
1. Med Res Rev. 1983 Jul-Sep;3(3):259-87 - PubMed
1. FASEB J. 1990 Nov;4(14):3178-88 - PubMed
1. Am J Cardiol. 1990 Aug 15;66(4):462-7 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information